Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Metabolic syndrome

Obesity Weekly News

Obesity Today—February 3, 2026

This weekly update in Obesity and Metabolic Disease highlights major regulatory…

Obesity Weekly News

Obesity Today—January 27, 2026

This week's Obesity update highlights late-stage clinical advancement, major…

Obesity Weekly News

Obesity Today—November 25, 2025

This week’s obesity update brings you the latest clinical advancements,…

Obesity Weekly News

Obesity Today—November 11, 2025

Track this week’s obesity headlines: Obesity Week 2025 highlights, industry…

EAS 2025 Preview: Atherosclerosis and Vascular Disease Highlights to Watch

EAS 2025 at a glance Prepare for EAS 2025 with LucidQuest’s quick…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Public Health Video Recap—February 13, 2026
Respiratory Today—February 13, 2026
Vaccines Today—February 13, 2026
Public Health Today—February 13, 2026
Healthcare and Pharma Industry Trends H2 2025: From Innovation to Execution

Tags

Alzheimers Research antifungals Biopharma Marketing Bispecifics Blood Pressure calcification-resistant tissue Capsida Biotherapeutics CD19/CD20 Cirtuvivint Competitive Intelligence Software content analytics COPD research CORE-MD CRSwNP Eye Health finerenone genomic medicine HCC IgG4RD IL-23 receptor Insulin Pump Long COVID Lunit INSIGHT Lyme Disease menopause mHSPC Mitochondrial Disease NRF2 NS Pharma OSA osteoporosis care p47CGD Patent litigation PD-L1 inhibitor Pila Pharma Polpharma Biologics Reblozyl seltorexant Sleep Technology T-cell lymphoma Thyroid Artery Embolization VK2735 Youth Health Zeposia Zoryve

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Public Health Video Recap—February 13, 2026
Respiratory Today—February 13, 2026
Vaccines Today—February 13, 2026
Public Health Today—February 13, 2026
Healthcare and Pharma Industry Trends H2 2025: From Innovation to Execution

TAGS

Alzheimers Research antifungals Biopharma Marketing Bispecifics Blood Pressure calcification-resistant tissue Capsida Biotherapeutics CD19/CD20 Cirtuvivint Competitive Intelligence Software content analytics COPD research CORE-MD CRSwNP Eye Health finerenone genomic medicine HCC IgG4RD IL-23 receptor Insulin Pump Long COVID Lunit INSIGHT Lyme Disease menopause mHSPC Mitochondrial Disease NRF2 NS Pharma OSA osteoporosis care p47CGD Patent litigation PD-L1 inhibitor Pila Pharma Polpharma Biologics Reblozyl seltorexant Sleep Technology T-cell lymphoma Thyroid Artery Embolization VK2735 Youth Health Zeposia Zoryve

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy